BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Other News

sanofi-aventis, Seikagaku, Zimmer autoimmune news

sanofi-aventis' Genzyme Corp. subsidiary filed suit against Seikagaku and Zimmer in the U.S. District Court for the District of Massachusetts claiming that Seikagaku's Gel-One infringes U.S. patent No. 5,399,351. The '351 patent covers the use of biocompatible viscoelastic...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >